The average relative dose intensity of R‐CHOP is an independent factor determining favorable overall survival in diffuse large B‐cell lymphoma patients
Abstract The prognosis of diffuse large B‐cell lymphoma (DLBCL) patients depends on lymphoma‐ and patient‐related risk factors and is best estimated by the international prognostic index (IPI). The aim of the study was to determine whether the average relative dose intensity (ARDI) of an anthracycli...
Saved in:
| Main Authors: | Monika Długosz‐Danecka, Sebastian Szmit, Tomasz Ogórka, Aleksander B. Skotnicki, Wojciech Jurczak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-03-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.2008 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of cyclophospamide, doxorubicin, vincristine and prednisone/prednisolone (CHOP) chemotherapy regimens on left ventricular systolic function and cardiac structural abnormalities in non-Hodgkin lymphoma patients
by: Imanita Septianda, et al.
Published: (2025-05-01) -
Cardiovascular system state changes in non-Hodgkin’s lymphoma patients during chemotherapy
by: A.-S. O. Bady, et al.
Published: (2020-05-01) -
Non-Hodgkin's lymphoma in the practice of the family doctor (clinical observation).
by: I. V. Vasylevska
Published: (2018-05-01) -
Biomaterial-based drug delivery: evaluating the safety profiles of liposomal Vyxeos
by: Zhicheng Liu, et al.
Published: (2025-12-01) -
The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma
by: T. D. Lutskaya, et al.
Published: (2014-07-01)